A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)

Trial Identifier:	D9483C00001
Sponsor:	AstraZeneca
NCTID::	NCT03283267
Start Date:	October 2017
Primary Completion Date:	November 2017
Study Completion Date:	November 2017
Condition:	Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	Chinese Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Hong Kong	Hong Kong, Hong Kong, NA

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.